Vanda Pharmaceuticals
VNDA
VNDA
177 hedge funds and large institutions have $396M invested in Vanda Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 61 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
35% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 31
48% less call options, than puts
Call options by funds: $17K | Put options by funds: $33K
Holders
177
Holding in Top 10
–
Calls
$17K
Puts
$33K
Top Buyers
| 1 | +$9.14M | |
| 2 | +$5.6M | |
| 3 | +$5.17M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$3.84M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.19M |
Top Sellers
| 1 | -$9.78M | |
| 2 | -$4.69M | |
| 3 | -$4.11M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$2.32M |
| 5 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$2.09M |